PL2331682T3 - Szczepionki przeciwko zakaźnemu zapaleniu oskrzeli pochodzące ze szczepów IB podobnych do QX - Google Patents
Szczepionki przeciwko zakaźnemu zapaleniu oskrzeli pochodzące ze szczepów IB podobnych do QXInfo
- Publication number
- PL2331682T3 PL2331682T3 PL09791266T PL09791266T PL2331682T3 PL 2331682 T3 PL2331682 T3 PL 2331682T3 PL 09791266 T PL09791266 T PL 09791266T PL 09791266 T PL09791266 T PL 09791266T PL 2331682 T3 PL2331682 T3 PL 2331682T3
- Authority
- PL
- Poland
- Prior art keywords
- strains
- infectious bronchitis
- vaccines derived
- bronchitis vaccines
- derived
- Prior art date
Links
- 206010006451 bronchitis Diseases 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000002458 infectious effect Effects 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/08—Inactivation or attenuation by serial passage of virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/544—Mucosal route to the airways
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20061—Methods of inactivation or attenuation
- C12N2770/20064—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8722808P | 2008-08-08 | 2008-08-08 | |
| PCT/US2009/053085 WO2010017440A1 (en) | 2008-08-08 | 2009-08-07 | Infectious bronchitis vaccines derived from ib-qx-like strains |
| EP09791266.1A EP2331682B1 (en) | 2008-08-08 | 2009-08-07 | Infectious bronchitis vaccines derived from ib-qx-like strains |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2331682T3 true PL2331682T3 (pl) | 2019-03-29 |
Family
ID=41211689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09791266T PL2331682T3 (pl) | 2008-08-08 | 2009-08-07 | Szczepionki przeciwko zakaźnemu zapaleniu oskrzeli pochodzące ze szczepów IB podobnych do QX |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US9296991B2 (pl) |
| EP (1) | EP2331682B1 (pl) |
| JP (3) | JP2011530294A (pl) |
| KR (2) | KR101732240B1 (pl) |
| CN (1) | CN102239252B (pl) |
| AR (1) | AR072976A1 (pl) |
| AU (1) | AU2009279528A1 (pl) |
| BR (1) | BRPI0917447A2 (pl) |
| CA (1) | CA2732822C (pl) |
| CL (1) | CL2011000262A1 (pl) |
| CO (1) | CO6351810A2 (pl) |
| CY (1) | CY1121567T1 (pl) |
| DK (1) | DK2331682T3 (pl) |
| ES (1) | ES2702089T3 (pl) |
| HU (1) | HUE041481T2 (pl) |
| LT (1) | LT2331682T (pl) |
| ME (1) | ME01270B (pl) |
| MX (1) | MX339731B (pl) |
| PL (1) | PL2331682T3 (pl) |
| PT (1) | PT2331682T (pl) |
| RU (1) | RU2568053C2 (pl) |
| SI (1) | SI2331682T1 (pl) |
| TR (1) | TR201819340T4 (pl) |
| UA (1) | UA103330C2 (pl) |
| WO (1) | WO2010017440A1 (pl) |
| ZA (1) | ZA201100849B (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104995315A (zh) | 2012-12-18 | 2015-10-21 | 梅里亚股份有限公司 | Ibv、csfv和ndv的高分辨熔解基因分型 |
| CN103028112B (zh) * | 2012-12-31 | 2014-08-06 | 青岛易邦生物工程有限公司 | 一种鸡新城疫和传染性支气管炎二联活疫苗 |
| CN103146654B (zh) * | 2013-03-25 | 2014-07-30 | 浙江诺倍威生物技术有限公司 | 一株人工弱化的鸡传染性支气管炎病毒及其应用 |
| KR20210068602A (ko) | 2016-06-02 | 2021-06-09 | 조에티스 서비시즈 엘엘씨 | 감염성 기관지염에 대한 백신 |
| CN108950068B (zh) * | 2018-07-18 | 2021-05-07 | 浙江大学 | 一种鸡传染性支气管炎病毒qx型毒株鉴别检测试剂盒 |
| AR116876A1 (es) * | 2018-10-31 | 2021-06-23 | Boehringer Ingelheim Vetmedica Gmbh | Vacuna de ibv 4/91 con proteína espicular heteróloga |
| EP3966228A1 (en) | 2019-05-10 | 2022-03-16 | Boehringer Ingelheim Vetmedica GmbH | Modified s2 subunit of the coronavirus spike protein |
| WO2024019579A1 (ko) * | 2022-07-22 | 2024-01-25 | 주식회사 카브 | 닭전염성기관지염바이러스 약독화주 및 이를 포함하는 백신조성물 |
| KR102717877B1 (ko) * | 2023-06-16 | 2024-10-16 | 주식회사 지나이너 | 외래 qx 유사 바이러스 스파이크 단백질을 포함하는 전염성 기관지염 키메라 바이러스 및 이를 포함하는 백신 조성물 |
| CN121941508A (zh) * | 2023-09-11 | 2026-04-28 | 勃林格殷格翰动物保健(中国)有限公司 | 减毒的传染性支气管炎病毒和包含其的疫苗 |
| GB2640725A (en) * | 2024-05-03 | 2025-11-05 | Genera Dionicko Drustvo | Vaccine |
| CN118546258B (zh) * | 2024-06-03 | 2024-11-29 | 中国动物卫生与流行病学中心 | 一种鸡传染性支气管炎病毒抗原表位融合肽及其在间接elisa检测中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4867975A (en) * | 1988-01-27 | 1989-09-19 | University Of Delaware | Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof |
| US5037650A (en) * | 1988-03-08 | 1991-08-06 | Akzo N.V. | Live combination vaccine |
| ATE196773T1 (de) * | 1993-07-30 | 2000-10-15 | Akzo Nobel Nv | Infektiösen bronchitis virus 4/91 enthaltender geflügel-impfstoff |
| JPH07206705A (ja) * | 1993-11-03 | 1995-08-08 | American Cyanamid Co | 生インオボ（ｉｎ ｏｖｏ）ワクチン |
| US20010046500A1 (en) | 2000-02-29 | 2001-11-29 | Berend Jongsma | In ovo protection against infectious bronchitis |
| WO2004078203A2 (en) | 2003-03-03 | 2004-09-16 | Akzo Nobel N.V. | Infectious bronchitis virus with an altered spike gene |
| US7291342B2 (en) | 2003-05-19 | 2007-11-06 | Intervet International B.V. | Infectious bronchitis virus vaccine |
-
2009
- 2009-08-06 AR ARP090103029 patent/AR072976A1/es not_active Application Discontinuation
- 2009-08-07 LT LTEP09791266.1T patent/LT2331682T/lt unknown
- 2009-08-07 MX MX2011001514A patent/MX339731B/es active IP Right Grant
- 2009-08-07 KR KR1020147036785A patent/KR101732240B1/ko active Active
- 2009-08-07 KR KR20117005375A patent/KR20110038181A/ko not_active Ceased
- 2009-08-07 BR BRPI0917447A patent/BRPI0917447A2/pt not_active Application Discontinuation
- 2009-08-07 ES ES09791266T patent/ES2702089T3/es active Active
- 2009-08-07 AU AU2009279528A patent/AU2009279528A1/en not_active Abandoned
- 2009-08-07 PL PL09791266T patent/PL2331682T3/pl unknown
- 2009-08-07 US US13/057,876 patent/US9296991B2/en active Active
- 2009-08-07 WO PCT/US2009/053085 patent/WO2010017440A1/en not_active Ceased
- 2009-08-07 EP EP09791266.1A patent/EP2331682B1/en active Active
- 2009-08-07 SI SI200931895T patent/SI2331682T1/sl unknown
- 2009-08-07 HU HUE09791266A patent/HUE041481T2/hu unknown
- 2009-08-07 JP JP2011522261A patent/JP2011530294A/ja active Pending
- 2009-08-07 ME MEP-2011-23A patent/ME01270B/me unknown
- 2009-08-07 CA CA2732822A patent/CA2732822C/en active Active
- 2009-08-07 RU RU2011104201/10A patent/RU2568053C2/ru active
- 2009-08-07 UA UAA201101392A patent/UA103330C2/ru unknown
- 2009-08-07 TR TR2018/19340T patent/TR201819340T4/tr unknown
- 2009-08-07 DK DK09791266.1T patent/DK2331682T3/en active
- 2009-08-07 CN CN200980139962.2A patent/CN102239252B/zh active Active
- 2009-08-07 PT PT09791266T patent/PT2331682T/pt unknown
-
2011
- 2011-02-01 ZA ZA2011/00849A patent/ZA201100849B/en unknown
- 2011-02-07 CL CL2011000262A patent/CL2011000262A1/es unknown
- 2011-02-08 CO CO11014593A patent/CO6351810A2/es not_active Application Discontinuation
-
2015
- 2015-03-05 JP JP2015043905A patent/JP2015144605A/ja active Pending
-
2017
- 2017-05-17 JP JP2017098049A patent/JP6397539B2/ja active Active
-
2018
- 2018-12-19 CY CY20181101380T patent/CY1121567T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201100849B (en) | Infectious bronchitis vaccines derived from ib-qx-like strains | |
| ZA201101481B (en) | Vaccine | |
| IL208660A0 (en) | Coccididosis vaccines | |
| ZA201007331B (en) | Vaccine | |
| PL2358386T3 (pl) | Zoptymalizowane szczepionki na grypę | |
| GB0822001D0 (en) | Vaccine | |
| IL212311A0 (en) | Immunoenhancer-linked oligomeric hiv vaccines | |
| GB0810710D0 (en) | Vaccine | |
| ZA201100889B (en) | Vaccine against hpv | |
| GB0906234D0 (en) | Vaccine | |
| ZA201007402B (en) | Vaccine | |
| ZA201100962B (en) | Influenza vaccines | |
| GB0816447D0 (en) | Vaccine | |
| GB0816284D0 (en) | Vaccine | |
| GB0907935D0 (en) | Vaccines | |
| GB0801326D0 (en) | Vaccines | |
| GB0900455D0 (en) | Vaccine | |
| EP2337847A4 (en) | ADJUVANTS FOR VACCINES | |
| EP2240199A4 (en) | INFLUENZA VACCINES | |
| GB0818459D0 (en) | Vaccines | |
| GB0806461D0 (en) | Anti-atheroma vaccine | |
| GB0810215D0 (en) | Vaccine | |
| GB0809781D0 (en) | Vaccine | |
| GB0810914D0 (en) | Vaccine | |
| AU2008267307A1 (en) | Vaccine |